NCT06998875View on ClinicalTrials.gov

A Prospective Cohort Study on Primary Cutaneous Amyloidosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Primary Cutaneous Amyloidosis
Interventions
DRUG

Tofacitinib and Acitretin Capsules.

The same with Arms.

DRUG

Acitretin Capsules.

The same with Arms.

Trial Locations (1)

400038

RECRUITING

Department of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing

All Listed Sponsors
lead

Army Medical University, China

OTHER